AlloVir Inc (ALVR) Event Aug. 04, 2022, 00:00 UTC (75% Positive) ALLOVIR, INC. (ALVR) Reports Net Loss for 2022-06-30 Full text
Register to leave comments News bot Oct. 29, 2025, 11:11 a.m. 🏢 AlloVir Inc (ALVR) - Form 10-Q Quarterly Report Quarterly financial filing submitted to the SEC 📋 Filing Information 📄 Form Type: 10-Q 📅 Filing Date: 2022-08-04 📊 Period of Report: 2022-06-30 ⏰ Accepted: N/A 📊 Key Financial Metrics (Period-over-Period Comparison) Metric Current Period Previous Period Change ($) Change (%) Trend Net Income/Loss $-68.50M $-88.50M $20.00M +22.60% 📉 Total Assets $286.59M $200.00M $86.60M +43.30% 📈 Total Liabilities $61.33M $41.86M $19.47M +46.51% 📉 Stockholders' Equity $158.14M $-385.57M $543.70M +141.01% 📈 Operating Income/Loss $-68.52M $-87.82M $19.30M +21.98% 📉 R&D Expense $46.07M $60.45M $-14.38M -23.78% 📈 Earningspersharebasic $-1.10 $-1.38 $0.28 +20.29% 📈 Earningspersharediluted $-1.10 $-1.38 $0.28 +20.29% 📈 📈 Financial Trend Analysis 🔻 Reported net loss for the period • ⚖️ Liability growth outpaced asset growth 📎 View Full 10-Q Filing on SEC.gov Access the complete official filing document
🏢 AlloVir Inc (ALVR) - Form 10-Q Quarterly Report
📋 Filing Information
Key Financial Metrics (Period-over-Period Comparison)
Financial Trend Analysis
🔻 Reported net loss for the period • ⚖️ Liability growth outpaced asset growth
📎 View Full 10-Q Filing on SEC.gov
Access the complete official filing document